COVID-19 Risk and Increased Hepatic ACE2 Expression in NAFL and Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?
Diabetes Care 2020 Aug 04;[EPub Ahead of Print], J Soldo, M Heni, A Königsrainer, HU Häring, AL Birkenfeld, A PeterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.